Stepwise mitochondria‐targeted photodynamic immunotherapy enabled by an outer membrane vesicles‐based nanoplatform for synergistic tumor ablation and immune reprogramming
Open Access
- 19 February 2026
- journal article
- Published by Wiley in Smart Molecules
- Vol. 4 (2)
Abstract
Photodynamic immunotherapy (PDIT) integrates reactive oxygen species (ROS)‐mediated tumor destruction with immune activation. However, its effectiveness is often hindered by tumor hypoxia, poor tumor‐targeted delivery, and the immunosuppressive microenvironment. Here, we introduce BDPM@OMVs , a biomimetic nanoplatform designed to overcome these challenges. This system uses bacterial outer membrane vesicles to encapsulate a novel, heavy‐atom‐free aggregation‐induced emission photosensitizer ( BDPM ). Our platform enables stepwise lysosome‐to‐mitochondria trafficking for enhanced PDIT. BDPM@OMVs exhibits strong near‐infrared absorption and efficient intersystem crossing, leading to both Type I and Type II ROS generation, which sustains photodynamic performance even under hypoxic conditions. Upon light irradiation, BDPM@OMVs trigger photochemical internalization (PCI), disrupting lysosomes and releasing BDPM into the cytosol. The freed BDPM then selectively accumulates in mitochondria, where continues light exposure generates robust ROS, causing mitochondrial dysfunction and activating apoptosis. This process effectively amplifies tumor cell eradication. Simultaneously, BDPM@OMVs reprogram the tumor immune microenvironment by promoting macrophage repolarization from the immunosuppressive M2 to the pro‐inflammatory M1 phenotype, as evidenced by upregulated TNF‐α, IL‐1β, and CD86 expression. In vivo studies confirm that BDPM@OMVs achieve efficient tumor accumulation, allow for real‐time NIR imaging, and provide superior therapeutic outcomes. This work presents a versatile and hypoxia‐resilient PDIT strategy that synergistically integrates precise subcellular photodamage with immune modulation to overcome resistance in solid tumors.Keywords
This publication has 43 references indexed in Scilit:
- Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B CellsAdvanced Materials, 2025
- Chemiluminescent Afterglow Material for Enhanced Tumor Diagnosis and Photodynamic TherapyAdvanced Functional Materials, 2024
- Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic ImmunotherapyAdvanced Materials, 2024
- Photoresponsive Ru Metalloprodrug Assemblies: Red‐Light‐Controlled Self‐Delivery Systems for Enhanced Anticancer PhototherapyAdvanced Functional Materials, 2024
- Achieving Efficient NIR‐II Type‐I Photosensitizers for Photodynamic/Photothermal Therapy upon Regulating Chalcogen ElementsAdvanced Materials, 2021
- BODIPY‐Based Photodynamic Agents for Exclusively Generating Superoxide Radical over Singlet OxygenAngewandte Chemie International Edition, 2021
- Acceptor Engineering for Optimized ROS Generation Facilitates Reprogramming Macrophages to M1 Phenotype in Photodynamic ImmunotherapyAngewandte Chemie International Edition, 2020
- Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer TherapyAdvanced Materials, 2020
- Electromagnetic Nanomedicines for Combinational Cancer ImmunotherapyAngewandte Chemie International Edition, 2020
- Molecular Design of Highly Efficient Heavy‐Atom‐Free Triplet BODIPY Derivatives for Photodynamic Therapy and BioimagingAngewandte Chemie International Edition, 2020